Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR., COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011 Aug 25;365(8):689-98. \[[PMC free article: PMC3220999](/pmc/articles/PMC3220999/)\] \[[PubMed: 21864166](https://pubmed.ncbi.nlm.nih.gov/21864166)\] 22. de Jong YP, Uil SM, Grotjohan HP, Postma DS, Kerstjens HA, van den Berg JW. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. Chest. 2007 Dec;132(6):1741-7. \[[PubMed: 17646228](https://pubmed.ncbi.nlm.nih.gov/17646228)\] 23. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015 Feb 23;2015(2):CD003793. \[[PMC free article: PMC10008021](/pmc/articles/PMC10008021/)\] \[[PubMed: 25705944](https://pubmed.ncbi.nlm.nih.gov/25705944)\] 24. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 04;350(10):1005-12. \[[PubMed: 14999112](https://pubmed.ncbi.nlm.nih.gov/14999112)\] 25. Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01;191(1):19-33. \[[PubMed: 25369325](https://pubmed.ncbi.nlm.nih.gov/25369325)\] **Disclosure:** Anuj Agarwal declares no relevant financial relationships with ineligible companies. **Disclosure:** Avais Raja declares no relevant financial relationships with ineligible companies. **Disclosure:** Brandon Brown declares no relevant financial relationships with ineligible companies.